Business

HLS Therapeutics to Host Q4 and Fiscal 2019 Financial Results Conference Call

HLS Therapeutics to Host Q4 and Fiscal 2019 Financial Results Conference Call Cana...

articleHls Therapeutics, Inc.February 27, 20205/company/hls-therapeutics-inc/news/hls-therapeutics-to-host-q4-and-fiscal-2019-financial-results-conference-call
HLS Therapeutics to Host Q4 and Fiscal 2019 Financial Results Conference Call

About this update from Hls Therapeutics, Inc.

[{"type":"text","content":"\n\n\n\nHLS Therapeutics to Host Q4 and Fiscal 2019 Financial Results Conference Call\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen4{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: TOP; BORDER-BOTTOM:black 0pt; TEXT-ALIGN: LEFT; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prngen3{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: TOP; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prngen2{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prnsbt0{\nBORDER-TOP:0pt\n}\n.prnsbr0{\nBORDER-RIGHT:0pt\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n.prnsbl0{\nBORDER-LEFT:0pt\n}\n.prnsbb0{\nBORDER-BOTTOM:0pt\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, Feb. 27, 2020\n\n\n\nTORONTO, Feb. 27, 2020 /CNW/ - HLS Therapeutics Inc. (\"HLS\" or the \"Company\") (TSX: HLS), a specialty pharmaceutical company specializing in central nervous system and cardiovascular markets, announces that it will release its fourth quarter and fiscal 2019 financial results by press release at 6:30 a.m. Eastern Time on Thursday, March 19, 2020. The Company will hold a conference call that same day at 8:30 a.m. Eastern Time to discuss its results. The call will be hosted by Mr. Greg Gubitz, Chief Executive Officer, Mr. Gilbert Godin, President and Chief Operating Officer and Mr. Tim Hendrickson, Chief Financial Officer. \nCONFERENCE CALL DETAILS \nDATE:                           \nThursday, March 19, 2020\nTIME:                           \n8:30 a.m. Eastern Time\nDIAL-IN NUMBER:   \n(888) 231-8191 or (647) 427-7450 \nWEBCAST LINK:        \nhttps://event.on24.com/wcc/r/2201043/DA0B5FD59F197...

More updates from Hls Therapeutics, Inc.